RecruitingNot ApplicableNCT07253987

Cancer Survivors Program

Cancer Survivors Program: Effectiveness of Monitoring Adverse Events After Completion of Curative Treatment for Breast and Prostate Cancer


Sponsor

Masaryk Memorial Cancer Institute

Enrollment

200 participants

Start Date

May 5, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The questionnaire for assessment of adverse events after completion of cancer treatment, which is being piloted at the Masaryk Memorial Cancer Institute, aims to detect a wide range of adverse effects early on, thus facilitating adequate intervention and planning of follow-up care for all cancer survivors.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is designed for people who have finished their main cancer treatment for breast or prostate cancer and are now in the survivorship phase. The program aims to support their health and wellbeing after active treatment ends. **You may be eligible if...** - You are 18 or older - You have been diagnosed with invasive breast cancer or invasive prostate cancer - You have completed the main phase of your cancer treatment (surgery, chemotherapy, and/or radiation) - You are available for follow-up within 12 months of joining the study **You may NOT be eligible if...** - You are still undergoing active cancer treatment (with some exceptions for hormone therapy, targeted therapy, or immunotherapy) - Your cancer has come back or spread to other parts of your body - You have had a second type of cancer (other than certain skin cancers) - You had breast cancer but did not receive chemotherapy as part of your treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERactive screening of adverse effects of anticancer therapy based on specific questionnaire + quality of life screening

Based on the Questionnaire for the Assessment of Difficulties after the completion of cancer treatment, the attending physician will assess the need for intervention and respond appropriately to the reported problems. Intervention is assessed as education by the physician, the use of medication, or referral of the patient to a specialized outpatient clinic.


Locations(1)

Masaryk Memorial Cancer Institute

Brno, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07253987


Related Trials